SEC Form D private-offering filing
IMMUNIC, INC.
A new SEC Form D private-offering notice from New York, a $200,000,000 filer-stated offering target in Biotech. The source filing is one click away.
Clinical-stage biotechnology company developing oral, small-molecule therapies for chronic inflammatory, autoimmune, and neurologic diseases, including relapsing multiple sclerosis.
Filed 2026-03-04Filed to raise $200,000,000First money in 2026-02-17Raised so far $200,000,000HQ (as filed) New YorkSector Biotech ✓Stage (inferred) LateCall status Non-US principal office
Source linked the Form D on EDGAR↗Website verified imux.com↗Named in the filing 14 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.